187 related articles for article (PubMed ID: 29883599)
21. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
[TBL] [Abstract][Full Text] [Related]
22. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
[TBL] [Abstract][Full Text] [Related]
23. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
[TBL] [Abstract][Full Text] [Related]
24. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
[TBL] [Abstract][Full Text] [Related]
25. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.
Cattaneo C; Di Blasi R; Skert C; Candoni A; Martino B; Di Renzo N; Delia M; Ballanti S; Marchesi F; Mancini V; Orciuolo E; Cesaro S; Prezioso L; Fanci R; Nadali G; Chierichini A; Facchini L; Picardi M; Malagola M; Orlando V; Trecarichi EM; Tumbarello M; Aversa F; Rossi G; Pagano L;
Ann Hematol; 2018 Sep; 97(9):1717-1726. PubMed ID: 29705860
[TBL] [Abstract][Full Text] [Related]
27. Comparison of characteristics of bacterial bloodstream infection between adult patients with allogeneic and autologous hematopoietic stem cell transplantation.
Hong J; Moon SM; Ahn HK; Sym SJ; Park YS; Park J; Cho YK; Cho EK; Shin DB; Lee JH
Biol Blood Marrow Transplant; 2013 Jun; 19(6):994-9. PubMed ID: 23571460
[TBL] [Abstract][Full Text] [Related]
28. Comparison of antibiotic prophylaxis with cotrimoxazole/colistin (COT/COL) versus ciprofloxacin (CIP) in patients with acute myeloid leukemia.
Mayer K; Hahn-Ast C; Mückter S; Schmitz A; Krause S; Felder L; Bekeredjian-Ding I; Molitor E; Brossart P; von Lilienfeld-Toal M
Support Care Cancer; 2015 May; 23(5):1321-9. PubMed ID: 25617073
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials.
Egan G; Robinson PD; Martinez JPD; Alexander S; Ammann RA; Dupuis LL; Fisher BT; Lehrnbecher T; Phillips B; Cabral S; Tomlinson G; Sung L
Cancer Med; 2019 Aug; 8(10):4536-4546. PubMed ID: 31274245
[TBL] [Abstract][Full Text] [Related]
30. Treatment with fluorated quinolones of febrile neutropenia in patients with hematologic malignancies.
Nenova IS; Goranov SE; Mateva NG; Ananoshtev NH
Folia Med (Plovdiv); 2003; 45(1):13-9. PubMed ID: 12943062
[TBL] [Abstract][Full Text] [Related]
31. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
[TBL] [Abstract][Full Text] [Related]
32. Effects on spectrum and susceptibility patterns of isolates causing bloodstream infection by restriction of fluoroquinolone prophylaxis in a hematology-oncology unit.
Saito T; Yoshioka S; Iinuma Y; Takakura S; Fujihara N; Ichinohe T; Ishikawa T; Uchiyama T; Ichiyama S
Eur J Clin Microbiol Infect Dis; 2008 Mar; 27(3):209-16. PubMed ID: 18058141
[TBL] [Abstract][Full Text] [Related]
33. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
34. Impact of fluoroquinolone prophylaxis on infectious-related outcomes after hematopoietic cell transplantation.
Clemmons AB; Gandhi AS; Albrecht B; Jacobson S; Pantin J
J Oncol Pharm Pract; 2019 Mar; 25(2):326-332. PubMed ID: 29059026
[TBL] [Abstract][Full Text] [Related]
35. Predictive and risk factor analysis for bloodstream infection in high-risk hematological patients with febrile neutropenia: post-hoc analysis from a prospective, large-scale clinical study.
Okamoto A; Kanda Y; Kimura SI; Oyake T; Tamura K;
Int J Hematol; 2021 Oct; 114(4):472-482. PubMed ID: 34170481
[TBL] [Abstract][Full Text] [Related]
36. Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.
Cruciani M; Malena M; Bosco O; Nardi S; Serpelloni G; Mengoli C
J Clin Oncol; 2003 Nov; 21(22):4127-37. PubMed ID: 14615441
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
Gafter-Gvili A; Fraser A; Paul M; Leibovici L
Ann Intern Med; 2005 Jun; 142(12 Pt 1):979-95. PubMed ID: 15968013
[TBL] [Abstract][Full Text] [Related]
38. Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
Shinohara A; Yoshiki Y; Masamoto Y; Hangaishi A; Nannya Y; Kurokawa M
Leuk Lymphoma; 2013 Apr; 54(4):794-8. PubMed ID: 22978686
[TBL] [Abstract][Full Text] [Related]
39. Three-day treatment with imipenem for unexplained fever during prolonged neutropaenia in haematology patients receiving fluoroquinolone and fluconazole prophylaxis: a prospective observational safety study.
Slobbe L; Waal Lv; Jongman LR; Lugtenburg PJ; Rijnders BJ
Eur J Cancer; 2009 Nov; 45(16):2810-7. PubMed ID: 19647995
[TBL] [Abstract][Full Text] [Related]
40. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]